Quick answer: Adiponectin is a hormone made by fat tissue that helps muscles and the liver respond to insulin. Lower levels generally go along with more body fat and insulin resistance, and in a meta-analysis of 13 prospective studies higher adiponectin was associated with a lower risk of type 2 diabetes. In older adults and people with heart failure, very high levels have been associated with higher mortality, so context matters.
Fat tissue is not just storage. It is an active organ that releases hormones, and adiponectin is one of the most studied. Unlike most signals from fat tissue, adiponectin tends to fall as body fat increases. It helps the liver and muscles use glucose and burn fatty acids, and it has anti-inflammatory effects. That makes it an interesting window into how well fat tissue is doing its job, and it appears on some advanced cardiometabolic panels alongside insulin, leptin and HOMA-IR.
This article is educational. It explains what the marker reflects and how researchers connect it to the deeper mechanisms of aging, so you can have a more informed conversation with your own provider.
What does a low or high adiponectin level mean?
Adiponectin generally runs opposite to body fat. As fat tissue expands, it releases less adiponectin, so lower levels tend to travel with insulin resistance, higher triglycerides and chronic low-grade inflammation. Levels also vary from person to person for inherited reasons, as a study of very long-lived families suggested, which is one reason a single number is best read in context.
A higher level is usually seen as favorable in middle-aged, generally healthy adults. The picture changes later in life and in people with heart disease, a pattern researchers call the adiponectin paradox. In older adults with heart failure or atrial fibrillation, and at very high levels in older adults generally, higher adiponectin has been associated with higher mortality. It may partly reflect weight loss, frailty or a body that is under strain rather than good metabolic health, which is why adiponectin is never read on its own.
Adiponectin circulates in several sizes. Some panels report total adiponectin and some report the high-molecular-weight form, and in the large older-adult study described below the two gave similar results. It is still worth knowing which one appears on a report.
How is adiponectin connected to aging and root causes?
Adiponectin sits close to nutrient sensing, one of the central processes in aging biology. In laboratory and animal work published in 2002, Yamauchi and colleagues showed that adiponectin activates AMPK, an energy sensor inside cells, which increased glucose uptake and fat burning in muscle and reduced glucose production in the liver. AMPK is the same pathway that exercise and lower calorie intake switch on, and it supports autophagy, the cell’s recycling program. That work was done in cells and mice, so it explains a mechanism rather than proving what happens in people.
Adiponectin is also part of intercellular signaling between fat tissue and the rest of the body. When fat tissue is stressed, it tends to release more inflammatory signals such as IL-6 and TNF-alpha and less adiponectin, which feeds chronic low-grade inflammation. Senescent cells that build up in fat tissue may add to that inflammatory mix, and healthy mitochondria in fat and muscle support normal fat cell function, although direct human data tying these processes to adiponectin levels are still early.
There is also an intriguing longevity angle. In a study of Ashkenazi Jewish families with exceptional longevity, Atzmon and colleagues found that people older than 95 had higher adiponectin than younger participants, independent of body mass index, and that the offspring of centenarians had higher levels than unrelated controls. Two common variants of the adiponectin gene were more frequent in long-lived men. That suggests genetics shape adiponectin, although it is an observational finding in one population.
From a root-cause view, the factors that shape adiponectin are mostly the factors that shape fat tissue health. Fat stored around the organs, which is driven by food quality, overall energy balance, alcohol and inactivity, tends to go along with lower levels. Poor sleep and ongoing stress push the body toward storing fat in that area. Regular movement and a fiber-rich, Mediterranean-style way of eating have been associated with higher levels in trials. Gut health and the microbiome may influence fat tissue inflammation, and everyday exposures and nutrient status are being studied, but those links are still early. Genetics sets part of the baseline.
What does the research show about adiponectin?
The strongest evidence comes from long-term studies of diabetes risk. In a 2009 systematic review and meta-analysis in JAMA, Li and colleagues pooled 13 prospective cohort studies with 14,598 participants, of whom 2,623 developed type 2 diabetes during follow-up. Higher adiponectin was steadily associated with lower risk, with a relative risk of 0.72 for each one-unit increase on a logarithmic scale, and the association was consistent across White, East Asian, Asian Indian, African American and Native American populations and across different lab methods. Because these were observational studies, they cannot show that raising adiponectin itself lowers risk, and adiponectin may partly be a sign of healthier fat tissue rather than a cause.
Lifestyle change appears to move adiponectin. In a two-year randomized trial in Italy published in JAMA in 2003, Esposito and colleagues assigned 120 premenopausal women with obesity, aged 20 to 46, either to a detailed program aimed at losing at least 10 percent of body weight through a lower-calorie Mediterranean-style diet and more physical activity, or to general advice about healthy food and exercise. After two years, body mass index fell by 4.2 points more in the program group, inflammatory markers such as IL-6 and CRP fell, and adiponectin rose by 2.2 micrograms per milliliter more than in the control group. Changes in adiponectin were independently associated with improvements in insulin sensitivity. The trial was single-blind, included only younger women with obesity and changed diet, activity and weight at the same time, so it cannot say which part made the difference.
Higher is not always better later in life. In the Cardiovascular Health Study, Kizer and colleagues measured total and high-molecular-weight adiponectin in 4,685 community-dwelling adults aged 65 and older and grouped them by heart status. In those without heart disease, heart failure or atrial fibrillation, the relationship with death was U-shaped. Rising total adiponectin up to about 12.4 mg/L was associated with lower mortality (hazard ratio 0.81 per standard deviation), but above that point higher levels were associated with higher mortality (hazard ratio 1.19). In people with heart failure or atrial fibrillation, higher adiponectin was associated with higher mortality across the range. This was an observational study, so it cannot separate cause from effect, and very high levels in older adults may reflect weight loss or illness.
Exercise studies point the same way as the diet trial. A 2023 meta-analysis of 40 randomized trials with 2,160 people with type 2 diabetes by García-Hermoso and colleagues found that exercise training changed adiponectin and several other exercise-related signals compared with control groups, with somewhat stronger effects in programs longer than 24 weeks. Those trials were in people who already had diabetes, so the results may not carry over to everyone.
Related reading
If you would like to explore related topics, my articles on fasting insulin and HOMA-IR, the triglyceride-to-HDL ratio and TNF-alpha go deeper. You can also see the specialty tests I commonly recommend on my functional labs page.
Common questions about Adiponectin
Is higher adiponectin always better?
Not always. In middle-aged adults higher levels are generally associated with better metabolic health, but in older adults and people with heart failure, very high levels have been associated with higher mortality, a pattern researchers call the adiponectin paradox.
Why does adiponectin go down when body fat goes up?
As fat tissue expands, it releases less adiponectin. That is part of why lower levels tend to go along with insulin resistance and higher inflammatory markers.
Can lifestyle changes raise adiponectin?
In a two-year randomized trial of 120 women with obesity, a program combining a Mediterranean-style diet, more activity and weight loss raised adiponectin compared with general advice. A meta-analysis of exercise trials in people with type 2 diabetes also found changes in adiponectin.
Sources
This article is for educational purposes only and is not medical advice. It does not replace an individual evaluation. Talk with your healthcare provider before making changes to your diet, exercise, supplements, or medications, especially if you are pregnant, nursing, or managing a health condition.
Free: The 28-Day Reset for Energy and Focus
A simple day-by-day email guide to sleep, movement, food, and daily habits that support healthy aging. It’s free, and you can unsubscribe anytime.
Get the free guide Take the supplement quiz
